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INTRODUCTION

Table 1: ZIP code stratification for childhood lead testing

RESULTS

• There is no safe level of lead in the body.
• Elevated blood lead levels (>5 mcg/dL) primarily affect the
development of the central nervous system in infants and
young children potentially resulting in:
• Behavioral issues
• Mental health issues
• Learning disabilities
• Hearing loss
• Lead levels are highest between the ages of 18-36 months
due to an increase in mobility and hand-to-mouth behavior.
• Despite the national downtrend of childhood lead
poisoning, Milwaukee (MKE) continues to have a higher than
national average incidence of children testing positive for
lead exposure due to a high density of housing with leadbased paint and lead lateral water pipes.
• In MKE, children with Medicaid are recommended to be
screened for lead levels at 12, 18, and 24 months, followed
by annual screening through the age of 5.
• Only 32% of Medicaid enrolled children received screening
at 1 and 2 years of age in 2016 according to the Report on
Childhood Lead Poisoning in Wisconsin.

PURPOSE
To review the rate of appropriate lead screening in children
aged 12 to 35 months at Advocate Aurora Sinai’s Family Care
Center (FCC) and to identify risk factors for elevated blood lead
levels.

METHODS
• Retrospective chart review study (n=383) using Aurora
Health Care’s electronic health records and the Wisconsin
Lead Registry on children 12 through 35 months who
attended FCC for well child exams during 10/01/2018 to
9/30/2019.
• Screening results were sorted into the age groups of 12-17,
18-23, and 24-35 months, per screening recommendations.
The decision to include 24-35 months was intended to
capture all 2 year old patients.
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DISCUSSION
• Childhood lead screening rates at FCC (62%) were comparable to statewide
screening for the general pediatric population (67.6%) in 2016.
• Higher screening rates seen with Medicaid patients may be attributed to
the benefit of being a Women, Infants, and Children (WIC) member.

Figure 1: Childhood lead testing based on race

• Appropriate lead level screening rates of children were as follows: 45% for
12-17 months, 26% for 18-23 months, and 35% for 24-35 months. 62% of
children at FCC ages 1 and 2 years had at least one blood lead test.
• There was no statistically significant difference in screening based on
ethnicity as defined by Black vs non-Black (p=0.56), although Black was the
majority tested for lead exposure (Fig. 1). There was no statistically
significant difference in testing for male vs female patients (p=0.948).
• However, there was a statistically significant difference (p=0.016) between
insurance carriers, with Medicaid patients (n=342, 89.3%) screening more
than those with other insurance types (n=41, 10.7%).
• Certain ZIP codes in MKE had higher rates of lead screening (Tab. 1),
correlating with areas known to have higher levels of childhood lead
poisoning per the 2016 Report on Childhood Lead Poisoning in Wisconsin.

• Basic descriptive statistics were computed, and Fisher Exact
Test was used for categorical analysis.

• FCC will implement point of care (POC) lead testing which bypasses the
need for lab processing and increases screening accessibility. This will serve
as an excellent opportunity to continue data collection to compare
screening rates before and after implementation. We expect to see a
significant increase in screening rates.
• Future steps include community outreach and advocacy to understand and
confront increased blood lead levels and gather data from clinics with POC
testing to determine its efficacy.

Figure 2: FCC patient with two
granddaughters who tested
positive for elevated blood lead
levels and subsequently treated.
"Lead is not a new problem for me.
When I was raising my son and
daughter in Milwaukee, I used to
bring to them in weekly to have
their lead levels monitored. Back
then, I was given information
about diet and how to help get the
levels down. Here I am again with
my grandchild dealing with the
same problem.”
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